Table 2.

CPFA treatment features for heparin and citrate patients

	Heparin	Citrate	P
Patients (n)	7	5	–
CVC (n, jugular/femoral)	2/5	0/5	–
CPFA sessions (n)	15	16	–
CPFA duration (h)	6	6	–
Blood flow rate (mL/min)	150 (100–200)	150 (100–220)	0.67
Effluent volume (mL/session)	9 (5.1–15)	14.4 (5.1–26.4)	0.12
Fluid removal (mL/session)	0	0	–
Plasma treated (mL/session)	8.4 (6.4–11.5)	8.3 (4.4–11.5)	0.13
Plasma processed dose (L/kg/session)	0.10 (0.17–0.06)	0.10 (0.15–0.04)	0.91
Plasma volumes treated (volumes/session)	2.0 (1.3–3.2)	2.0 (1.0–3.2)	0.26
Heparin amount (IU/session)	4000 (7500–1500)	–	–
Circuit citratemia (mmol/L)	–	3.0	–

The results are showed as median and min/max range. The min/max range is defined within the brackets

CVC central venous catheter